Furthermore, in vivo assays utilizing two murine HCC models demonstrated that pharmacological inhibition of NUPR1 significantly suppressed tumor growth, accompanied by increased M1 macrophage polarization and enhanced CD8+ T cell activity. The gene discussed is CD8A; the disease is hepatocellular carcinoma.